for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Merit Medical Systems, Inc.

MMSI.OQ

Latest Trade

70.09USD

Change

5.17(+7.96%)

Volume

171,249

Today's Range

65.42

 - 

70.54

52 Week Range

39.45

 - 

70.54

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
64.92
Open
65.63
Volume
171,249
3M AVG Volume
5.40
Today's High
70.54
Today's Low
65.42
52 Week High
70.54
52 Week Low
39.45
Shares Out (MIL)
56.00
Market Cap (MIL)
3,924.85
Forward P/E
33.67
Dividend (Yield %)
--

Next Event

Q3 2021 Merit Medical Systems Inc Earnings Release

Latest Developments

More

Merit Medical Reports Results For Quarter Ended June 30, 2021

Merit Medical Reports Q4 NON-GAAP EPS Of $0.54

Merit Medical Systems Reaffirms 2020 Financial Guidance

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Merit Medical Systems, Inc.

Merit Medical Systems, Inc. is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices. Its endoscopy segment consists of gastroenterology and pulmonology medical devices, which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Within its segments, the Company offers products focused in four product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, and endoscopy.

Industry

Medical Equipment & Supplies

Contact Info

1600 W Merit Pkwy

SOUTH JORDAN, UT

84095-2416

United States

+1.801.2531600

https://www.merit.com/

Executive Leadership

Fred P. Lampropoulos

Chairman of the Board, President, Chief Executive Officer

Raul Parra

Chief Financial Officer, Treasurer

Justin J. Lampropoulos

President - EMEA Division

Joseph C. Wright

President - International Division

Ronald A. Frost

Chief Operating Officer

Key Stats

1.89 mean rating - 9 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

0.9K

2019

1.0K

2020

1.0K

2021(E)

1.0K
EPS (USD)

2018

1.690

2019

1.460

2020

1.650

2021(E)

1.933
Price To Earnings (TTM)
140.00
Price To Sales (TTM)
3.81
Price To Book (MRQ)
3.95
Price To Cash Flow (TTM)
42.77
Total Debt To Equity (MRQ)
29.46
LT Debt To Equity (MRQ)
28.71
Return on Investment (TTM)
1.90
Return on Equity (TTM)
1.68

Latest News

Latest News

BRIEF-Merit Medical Announces Agreement With Starboard

* MERIT MEDICAL SYSTEMS INC - ANNOUNCES FORMATION OF OPERATING COMMITTEE TO REVIEW MARGIN IMPROVEMENT INITIATIVES AND ESTABLISH TARGETS

BRIEF-Merit Medical Receives CE Mark For Wrapsody™ Endovascular Stent Graft System

* MERIT MEDICAL RECEIVES CE MARK FOR WRAPSODY™ ENDOVASCULAR STENT GRAFT SYSTEM Source text for Eikon: Further company coverage:

BRIEF-Starboard Value LP Takes Share Stake In Commvault Systems, Merit Medical Systems

* STARBOARD VALUE LP TAKES SHARE STAKE IN ACI WORLDWIDE INC OF 1.4 MILLION SHARES - SEC FILING

BRIEF-Merit Medical Systems Reports Q1 Non-GAAP EPS Of $0.38

* MERIT MEDICAL REPORTS EARNINGS FOR QUARTER ENDED MARCH 31, 2020, WITHDRAWS FY 2020 GUIDANCE

BRIEF-Merit Medical Systems Commenced Production Of A Sample Collection And Transport Kit Used To Collect Specimens With Suspected Presence Of Covid-19

* MERIT MEDICAL SYSTEMS - COMMENCED PRODUCTION OF A SAMPLE COLLECTION AND TRANSPORT KIT USED TO COLLECT SPECIMENS WITH SUSPECTED PRESENCE OF COVID-19

BRIEF-Merit Medical Receives Two Additional FDA Breakthrough Device Designations

* MERIT MEDICAL RECEIVES TWO ADDITIONAL FDA BREAKTHROUGH DEVICE DESIGNATIONS

BRIEF-Merit Medical Response to Earthquake in Salt Lake City

* MERIT MEDICAL SYSTEMS - THERE IS NO DAMAGE TO ANY OF CO'S FACILITIES IN UTAH DUE TO TO EARTHQUAKE Source text for Eikon: Further company coverage:

BRIEF-Merit Medical Forecasts 2020 GAAP Earnings Per Share Between $0.62 And $0.72

* MERIT MEDICAL REPORTS EARNINGS FOR FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2019, GIVES FY 2020 GUIDANCE

BRIEF-Merit Medical Systems Announces Four Regulatory Approvals

* MERIT MEDICAL SYSTEMS INC - RECEIVED CLEARANCE FROM CHINA NATIONAL MEDICAL PRODUCTS ASSOCIATION TO MARKET SWIFT NINJA STEERABLE MICROCATHETER

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up